INFINITY PHARMACEUTICALS, INC.: Nasdaq/NYSE listing notice — Infinity Pharma receives Nasdaq delisting notice for bid price noncompliance; plans appeal

INFINITY PHARMACEUTICALS, INC.

Nasdaq Staff determined to delist INFI for failure to regain compliance with minimum $1.00 bid price within 180-day period that began Dec 28, 2022.
Delisting scheduled for July 7, 2023 unless Company requests hearing by July 5, 2023; Company intends to request hearing.
Company also remains out of compliance with Nasdaq's market value of listed securities rule (minimum $50M) with grace period expiring October 2, 2023.
Hearing Panel can grant extension through December 26, 2023; no guarantee of regaining compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

INFINITY PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(A)

Exact text from the filing

April 4, 2023, the Company also received a deficiency letter from the Staff of Nasdaq notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5450(b)(2)(A) for continued listing on The Nasdaq Global Select Market, as the market value of the Company’s listed securities was less than $50,000,000 for the previous 30 consecutive business days and the Company does not meet any of the alternative listing requirements. The Company was granted a 180-day grace period to regain compliance with this requirement, which expires on October 2, 2023. As o

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

INFINITY PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

rom the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined to delist the Company’s common stock from The Nasdaq Global Select Market due to the Company not having regained compliance with Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Requirement”) during the 180-calendar-day period (the “Compliance Period”) following the deficiency letter the Company received from the Staff on December 28, 2022, regarding the Company’s noncompliance with the Minimum Bid Requirement, the receipt of which the Company

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001140361-23-032462

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.